S
AVDL

SignatureFD’s Avadel Pharmaceuticals AVDL Stock Holding History

SignatureFD’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-843
Closed -$18.2K – 3478
2025
Q4 		$18.2K Buy
843
+28
+3% +$544 ﹤0.01% 2164
2025
Q3 		$12.4K Hold
815
– – ﹤0.01% 2329
2025
Q2 		$7.21K Buy
815
+220
+37% +$1.93K ﹤0.01% 2463
2025
Q1 		$4.66K Buy
+595
New +$4.98K ﹤0.01% 2632
2024
Q4 		– Sell
-30
Closed -$393 – 3316
2024
Q3 		$393 Buy
30
+8
+36% +$122 ﹤0.01% 3125
2024
Q2 		$309 Hold
22
– – ﹤0.01% 3029
2024
Q1 		$372 Hold
22
– – ﹤0.01% 3056
2023
Q4 		$311 Buy
+22
New +$258 ﹤0.01% 3019
2023
Q2 		– Sell
-2,050
Closed -$18.8K – 3237
2023
Q1 		$18.8K Buy
2,050
+1,873
+1,058% +$15.4K ﹤0.01% 1906
2022
Q4 		$1.27K Buy
+177
New +$1.24K ﹤0.01% 2924

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SignatureFD's AVDL Position: Q1 2026 in Review

SignatureFD sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 843 shares — an estimated $18.2K sold.

SignatureFD first reported a position in AVDL in Q4 2022 and held it in 10 quarters. The position peaked at $18.8K in Q1 2023. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • SignatureFD reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SignatureFD sold 843 Avadel Pharmaceuticals shares in Q1 2026, an estimated $18.2K.
  • SignatureFD first reported a position in Avadel Pharmaceuticals in Q4 2022 and held it in 10 quarters.
  • SignatureFD's Avadel Pharmaceuticals position peaked at $18.8K in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.